Tyr635
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr635  -  PEAK1 (human)

Site Information
IVINPNAyDNLAIyK   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 449709
Available spectra:  4 CST
Associated spectra:  3 CST

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 ) , mutation of modification site ( 1 , 14 ) , phospho-antibody ( 14 ) , western blotting ( 14 )
Disease tissue studied:
atrial fibrillation ( 663 , 670 , 671 , 672 , 673 , 681 , 682 ) , adenoid cystic carcinoma ( 600 , 602 ) , bile-duct cancer ( 56 , 574 , 577 , 578 , 586 ) , bladder cancer ( 811 , 813 , 814 , 840 , 867 ) , bone cancer ( 20 , 712 , 713 , 714 , 722 , 723 , 724 , 1082 ) , Ewing's sarcoma ( 20 , 722 ) , osteosarcoma ( 20 , 712 , 713 , 714 , 723 , 724 , 1082 ) , brain cancer ( 20 , 110 , 111 , 122 , 164 , 390 , 391 , 392 , 393 , 394 , 395 , 631 , 691 , 701 , 729 , 864 , 866 , 931 , 953 , 962 , 965 , 969 , 978 , 982 , 983 , 984 , 992 , 1006 , 1007 , 1021 , 1058 , 1071 ) , astrocytoma ( 110 , 111 , 122 , 631 , 864 , 978 , 992 , 1071 ) , glioblastoma ( 164 , 390 , 391 , 392 , 393 , 394 , 395 , 931 , 953 , 965 , 982 , 983 , 984 , 1006 , 1007 , 1021 , 1058 ) , glioblastoma multiforme ( 691 , 701 , 729 , 953 , 983 , 1006 , 1007 ) , glioma ( 164 , 390 , 391 , 392 , 393 , 394 , 395 , 691 , 701 , 729 , 866 , 931 , 953 , 965 , 982 , 983 , 984 , 1006 , 1007 , 1021 , 1058 ) , oligodendroglioma ( 962 ) , Schwannoma ( 20 ) , breast cancer ( 7 , 11 , 14 , 19 , 165 , 221 , 229 , 273 , 420 , 463 , 659 , 661 , 662 , 674 , 700 , 730 , 731 , 732 , 806 , 807 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 837 , 841 , 842 , 846 , 872 , 878 , 883 , 981 , 1001 , 1008 , 1055 , 1056 , 1057 , 1080 , 1088 , 1089 ) , breast adenocarcinoma ( 14 , 883 , 1057 ) , breast ductal carcinoma ( 7 , 981 , 1001 ) , HER2 positive breast cancer ( 2 ) , luminal A breast cancer ( 2 ) , luminal B breast cancer ( 2 ) , breast cancer, surrounding tissue ( 221 , 273 , 420 ) , breast cancer, triple negative ( 2 , 7 , 14 , 165 , 828 , 829 , 1001 , 1008 ) , cervical cancer ( 356 ) , cervical adenocarcinoma ( 356 ) , colorectal cancer ( 1 , 20 , 67 , 68 , 69 , 103 , 108 , 109 , 118 , 119 , 222 , 531 , 658 , 706 , 707 , 708 , 709 , 710 , 754 , 853 , 888 , 889 , 890 , 894 , 895 , 928 , 929 , 930 , 951 , 952 , 1036 , 1037 , 1043 , 1069 , 1070 , 1074 , 1075 , 1093 ) , colorectal carcinoma ( 1 , 20 , 67 , 68 , 69 , 108 , 109 , 118 , 119 , 706 , 707 , 708 , 709 , 710 , 754 , 853 , 888 , 889 , 890 , 894 , 895 , 928 , 929 , 930 , 951 , 952 , 1036 , 1037 , 1043 , 1069 , 1070 , 1074 , 1075 , 1093 ) , colorectal cancer, surrounding tissue ( 203 , 204 , 224 , 226 , 526 , 532 ) , esophageal cancer ( 50 , 51 , 52 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 457 , 458 , 467 , 469 , 471 , 473 , 480 , 484 , 487 , 490 , 494 , 495 , 500 , 503 , 507 , 511 , 514 , 515 , 517 , 520 , 834 , 835 , 854 , 855 , 856 , 857 , 868 , 869 , 870 , 871 , 927 , 938 , 939 , 940 , 942 , 943 , 944 , 945 , 946 , 947 , 954 ) , esophageal carcinoma ( 290 , 291 , 292 , 293 , 294 , 295 , 296 , 298 , 299 , 834 , 835 , 868 , 869 , 871 , 942 , 943 , 944 , 945 , 946 , 954 ) , esophageal cancer, surrounding tissue ( 466 , 468 , 470 , 472 , 474 , 475 , 476 , 477 , 478 , 479 , 481 , 482 , 483 , 485 , 486 , 488 , 489 , 491 , 492 , 493 , 496 , 497 , 498 , 499 , 501 , 502 , 504 , 505 , 506 , 508 , 509 , 510 , 512 , 513 , 516 , 518 , 519 , 521 , 522 ) , liposarcoma ( 20 ) , gallbladder cancer ( 632 ) , gallbladder carcinoma ( 632 ) , gastric cancer ( 16 , 25 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 43 , 66 , 78 , 79 , 99 , 100 , 101 , 120 , 121 , 238 , 260 , 261 , 262 , 263 , 270 , 271 , 272 , 336 , 337 , 339 , 341 , 357 , 399 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 411 , 412 , 414 , 415 , 416 , 527 , 528 , 609 , 612 , 614 , 615 , 616 , 618 , 619 , 665 , 685 , 686 , 687 , 688 , 689 , 690 , 695 , 696 , 697 , 698 , 702 , 753 , 891 , 892 , 893 , 896 , 900 ) , gastric carcinoma ( 25 , 33 , 34 , 35 , 36 , 37 , 43 , 66 , 78 , 79 , 99 , 100 , 101 , 120 , 121 , 238 , 260 , 261 , 262 , 263 , 270 , 271 , 272 , 339 , 341 , 357 , 527 , 528 , 609 , 612 , 614 , 615 , 616 , 665 , 685 , 689 , 702 , 753 , 892 ) , gastric carcinoma, surrounding tissue ( 400 , 408 , 409 , 410 , 413 , 417 , 610 , 611 , 613 , 621 , 622 , 623 , 664 , 678 , 679 ) , kidney cancer ( 421 , 422 , 810 , 838 ) , kidney cancer, surrounding tissue ( 423 , 424 , 429 ) , leukemia ( 71 , 72 , 73 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 247 , 248 , 249 , 250 , 252 , 253 , 254 , 255 , 317 , 320 , 322 , 323 , 340 , 344 , 359 , 360 , 363 , 365 , 660 , 666 , 667 , 694 , 699 , 725 , 726 , 740 , 741 , 742 , 743 , 744 , 751 , 752 , 755 , 756 , 758 , 759 , 761 , 823 , 914 , 915 , 916 , 921 , 926 , 932 , 933 , 935 , 936 , 937 , 961 , 985 , 986 , 987 , 988 , 989 , 1025 , 1107 , 1108 , 1109 ) , chronic myelogenous leukemia ( 71 , 72 , 73 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 247 , 248 , 249 , 250 , 252 , 253 , 254 , 255 , 317 , 320 , 322 , 323 , 340 , 344 , 359 , 360 , 363 , 365 , 660 , 666 , 667 , 694 , 699 , 725 , 726 , 740 , 741 , 742 , 743 , 744 , 751 , 752 , 755 , 756 , 758 , 759 , 761 , 823 , 914 , 915 , 916 , 921 , 926 , 932 , 933 , 935 , 936 , 937 , 961 , 985 , 986 , 987 , 988 , 989 , 1025 , 1107 , 1108 , 1109 ) , liver cancer ( 201 , 283 , 284 , 285 , 286 , 439 , 448 , 449 , 450 , 524 , 525 , 537 , 538 , 539 , 541 , 543 , 544 , 545 , 555 , 573 , 576 , 584 , 587 , 633 , 634 , 635 , 648 , 649 ) , liver adenocarcinoma ( 525 ) , cholangiocellular carcinoma ( 201 , 538 , 555 , 648 ) , hepatocellular carcinoma ( 439 , 448 , 449 , 450 , 539 , 541 , 544 , 545 , 649 ) , hepatocellular carcinoma, surrounding tissue ( 440 , 441 , 442 , 443 , 444 , 445 , 446 , 540 , 542 , 554 , 650 , 652 , 653 ) , lung cancer ( 6 , 8 , 9 , 10 , 13 , 19 , 27 , 28 , 29 , 30 , 31 , 32 , 44 , 45 , 46 , 65 , 104 , 105 , 106 , 107 , 112 , 113 , 114 , 115 , 116 , 117 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 139 , 161 , 287 , 305 , 307 , 308 , 309 , 311 , 312 , 313 , 314 , 318 , 319 , 321 , 327 , 328 , 329 , 333 , 335 , 338 , 357 , 373 , 375 , 377 , 378 , 379 , 385 , 388 , 451 , 452 , 453 , 454 , 455 , 456 , 459 , 460 , 461 , 462 , 529 , 530 , 533 , 536 , 546 , 547 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 590 , 592 , 625 , 626 , 628 , 629 , 637 , 655 , 656 , 657 , 675 , 676 , 677 , 683 , 684 , 702 , 703 , 704 , 705 , 727 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 749 , 750 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 803 , 804 , 805 , 812 , 815 , 818 , 843 , 844 , 845 , 847 , 858 , 859 , 860 , 861 , 862 , 863 , 874 , 875 , 876 , 877 , 879 , 880 , 881 , 882 , 884 , 885 , 886 , 887 , 899 , 901 , 902 , 905 , 912 , 918 , 922 , 948 , 949 , 955 , 956 , 957 , 958 , 959 , 963 , 964 , 966 , 967 , 968 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 979 , 980 , 994 , 996 , 998 , 1000 , 1002 , 1004 , 1009 , 1010 , 1011 , 1012 , 1013 , 1016 , 1017 , 1018 , 1019 , 1020 , 1022 , 1023 , 1024 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1039 , 1041 , 1042 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1052 , 1059 , 1060 , 1063 , 1064 , 1066 , 1072 , 1073 , 1079 , 1081 , 1083 , 1084 , 1085 , 1087 , 1091 , 1096 , 1097 , 1098 , 1100 , 1101 , 1102 , 1103 ) , non-small cell lung cancer ( 6 , 8 , 10 , 12 , 15 , 17 , 18 , 19 , 27 , 28 , 29 , 30 , 31 , 32 , 44 , 45 , 46 , 65 , 104 , 105 , 106 , 107 , 112 , 113 , 114 , 115 , 116 , 117 , 126 , 127 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 139 , 327 , 328 , 329 , 333 , 335 , 373 , 375 , 377 , 378 , 379 , 385 , 388 , 451 , 461 , 529 , 530 , 533 , 536 , 546 , 547 , 557 , 558 , 559 , 560 , 561 , 592 , 625 , 626 , 637 , 655 , 656 , 657 , 675 , 676 , 677 , 683 , 684 , 702 , 703 , 704 , 705 , 727 , 733 , 737 , 738 , 739 , 749 , 750 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 786 , 787 , 788 , 795 , 796 , 797 , 798 , 799 , 803 , 804 , 805 , 843 , 844 , 845 , 847 , 858 , 859 , 860 , 861 , 862 , 863 , 877 , 879 , 880 , 881 , 882 , 884 , 885 , 886 , 887 , 899 , 901 , 902 , 905 , 912 , 918 , 922 , 948 , 949 , 955 , 956 , 957 , 958 , 959 , 963 , 964 , 968 , 974 , 975 , 976 , 977 , 980 , 1002 , 1004 , 1009 , 1011 , 1012 , 1013 , 1016 , 1017 , 1018 , 1019 , 1020 , 1022 , 1023 , 1024 , 1026 , 1027 , 1028 , 1029 , 1030 , 1032 , 1033 , 1034 , 1035 , 1039 , 1041 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1052 , 1059 , 1063 , 1064 , 1066 , 1072 , 1079 , 1083 , 1084 , 1085 , 1087 , 1091 , 1096 , 1097 , 1098 , 1100 , 1101 , 1102 , 1103 ) , non-small cell lung cancer, surrounding tissue ( 330 , 331 , 332 , 334 , 430 , 431 , 432 , 433 , 434 , 435 , 523 , 534 , 535 , 597 , 617 , 620 , 638 ) , non-small cell lung adenocarcinoma ( 6 , 8 , 9 , 10 , 12 , 13 , 44 , 46 , 65 , 106 , 107 , 114 , 115 , 116 , 117 , 126 , 127 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 139 , 357 , 373 , 375 , 377 , 378 , 379 , 385 , 388 , 451 , 557 , 558 , 559 , 560 , 561 , 625 , 626 , 655 , 656 , 657 , 702 , 737 , 738 , 739 , 815 , 818 , 875 , 876 , 1030 , 1041 , 1047 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 138 , 374 , 376 , 380 , 381 , 382 , 383 , 384 , 386 , 387 , 389 , 593 , 598 , 624 ) , non-small cell large cell lung carcinoma ( 10 , 812 ) , non-small cell squamous cell lung carcinoma ( 9 , 18 , 128 , 357 , 452 , 453 , 454 , 455 , 456 , 459 , 460 , 462 , 562 , 563 , 564 , 565 , 566 , 628 , 629 , 976 , 1009 , 1018 , 1034 , 1035 , 1079 , 1101 ) , non-small cell squamous cell lung carcinoma, surrounding tissue ( 627 ) , small-cell lung cancer ( 979 , 1060 ) , lung cancer, surrounding tissue ( 156 , 157 , 158 , 159 , 160 , 162 , 223 , 225 , 227 , 228 , 274 , 275 , 276 , 277 , 306 , 310 , 315 , 316 , 588 , 589 , 591 ) , lymphoma ( 288 , 897 , 960 , 1090 ) , B cell lymphoma ( 960 , 1090 ) , Hodgkin's lymphoma ( 288 , 897 ) , neuroblastoma ( 4 , 215 , 216 , 822 , 831 , 832 , 865 , 969 ) , oropharyngeal cancer ( 925 ) , squamous cell carcinoma of the oropharynx ( 925 ) , ovarian cancer ( 7 , 53 , 54 , 55 , 166 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 240 , 241 , 302 , 304 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 715 , 717 , 718 , 719 , 898 , 906 , 907 , 908 , 909 , 910 , 911 , 913 , 923 , 924 , 1003 ) , ovarian epithelial carcinoma ( 53 , 54 , 55 , 166 , 206 , 210 , 240 , 241 , 906 , 923 , 924 ) , pancreatic cancer ( 1105 , 1106 ) , prostate cancer ( 1092 ) , salivary gland cancer ( 581 , 582 ) , melanoma skin cancer ( 3 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 556 , 567 , 568 , 569 , 570 , 571 , 572 , 575 , 630 , 646 , 647 ) , non-melanoma skin cancer ( 1094 , 1095 ) , leiomyosarcoma ( 20 ) , rhabdomyosarcoma ( 20 ) , teratoma ( 326 ) , thymic carcinoma ( 141 , 142 , 143 , 144 ) , thyroid cancer ( 692 , 693 ) , ventricular tachycardia ( 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 )
Relevant cell line - cell type - tissue:
'fat, white' ( 20 ) , 'liver, para-cholangiocellular carcinoma tissue' ( 201 ) , 143.98.2 (bone cell) ( 724 ) , 143B (bone cell) ( 714 ) , 184A1 (epithelial) ( 447 ) , 23132/87 (gastric) [RAIG1 (human), knockdown] ( 38 ) , 23132/87 (gastric) ( 39 , 892 ) , 44-ZW-5409 (eye cell) ( 729 ) , 5637 (bladder cell) ( 840 ) , 639V (renal) ( 810 ) , A172 (glial) ( 1058 ) , A204 (muscle cell) ( 20 ) , A431 (epithelial) ( 1094 , 1095 ) , A498 (renal) ( 851 ) , A549 (pulmonary) [LKB1 (human), no information] ( 656 ) , A549 (pulmonary) ( 8 , 13 , 15 , 44 , 65 , 451 , 655 , 734 , 735 , 736 , 1073 , 1102 , 1103 ) , A673 (muscle cell) ( 20 ) , ACC-S (adenoidal) ( 599 , 601 ) , ACN ( 4 , 832 ) , AGS (gastric) ( 896 ) , AU565 (breast cell) ( 165 , 824 , 825 ) , BC-3C (bladder cell) ( 811 ) , BEAS-2B (epithelial) [LKB1 (human), knockdown] ( 251 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 550 , 551 ) , BEAS-2B (epithelial) ( 548 , 549 ) , breast ( 2 , 7 , 221 , 229 , 273 , 420 , 659 , 661 , 662 , 674 , 700 , 841 , 842 , 846 ) , BT-20 (breast cell) ( 19 , 165 , 731 , 732 ) , BT-474 (breast cell) ( 463 ) , BT-549 (breast cell) ( 14 , 19 , 165 ) , BxPC-3 (pancreatic) ( 1105 , 1106 ) , Caki-2 (renal) ( 839 , 849 , 852 ) , CAL-29 (bladder cell) ( 814 ) , CAL-51 (breast cell) ( 826 , 827 ) , CAL-85-1 (breast cell) ( 883 ) , Calu 6 (pulmonary) ( 19 ) , Calu-3 (pulmonary) ( 1031 , 1081 ) , Caov-3 (ovarian) ( 913 ) , cardiac-heart ( 167 , 171 , 172 , 176 , 179 , 183 , 185 , 190 ) , CCF-STTG1 (glial) ( 992 ) , cholangiocyte-liver ( 538 , 555 , 648 ) , CHP212 (neural crest) ( 4 ) , COLO-680N (esophageal) [RAIG1 (human), knockdown] ( 50 , 51 ) , COLO-680N (esophageal) ( 52 , 300 , 927 ) , COLO-699 (pulmonary) ( 881 ) , colon ( 203 , 204 , 222 , 224 , 226 , 526 , 531 , 532 , 658 ) , DBTRG-05MG (glial) ( 1006 ) , Detroit562 (squamous) ( 925 ) , DK-MG (glial) ( 953 ) , DLD1 (intestinal) ( 20 , 103 ) , DMS53 (pulmonary) ( 1060 ) , EFM-19 (breast cell) ( 165 , 848 ) , EFO-21 (ovarian) ( 908 ) , EFO-27 (ovarian) ( 909 ) , esophagus ( 457 , 458 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 ) , FU-OV-1 (ovarian) ( 898 ) , FU97 (gastric) ( 336 , 337 , 687 ) , GE11 ( 1 ) , GI-CA-N (neural crest) ( 4 , 822 ) , GI-ME-N (neuron) ( 4 , 831 ) , GMS-10 (glial) ( 965 ) , GOS-3 (glial) ( 962 ) , H2009 (pulmonary) ( 19 ) , H2077 (pulmonary) ( 19 ) , H2887 (pulmonary) ( 19 ) , H322M (pulmonary) ( 19 ) , H4 (glial) ( 931 ) , HCC1143 (breast cell) ( 165 , 1001 ) , HCC1395 (breast cell) ( 165 , 981 ) , HCC15 (pulmonary) ( 9 , 905 , 912 ) , HCC1569 (breast cell) ( 165 ) , HCC1599 (breast cell) ( 165 , 806 , 807 ) , HCC1806 (breast cell) ( 165 , 1008 ) , HCC366 (pulmonary) ( 1063 ) , HCC38 (breast cell) ( 165 , 828 ) , HCC44 (pulmonary) ( 1049 ) , HCC70 (breast cell) ( 165 , 829 ) , HCC78 (pulmonary) ( 10 , 116 , 117 , 1048 ) , HCC827 (pulmonary) ( 702 , 737 , 738 , 739 , 1030 ) , HCT116 (intestinal) ( 67 , 68 , 69 , 108 , 109 , 118 , 119 , 754 , 890 , 1074 , 1075 ) , HCT15 (intestinal) ( 928 , 929 ) , HCT8 (intestinal) ( 930 ) , HDQ-P1 (breast cell) ( 165 , 872 ) , heart ( 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 168 , 169 , 170 , 173 , 174 , 175 , 177 , 178 , 180 , 181 , 182 , 184 , 186 , 187 , 188 , 189 , 191 , 654 , 663 , 668 , 669 , 670 , 671 , 672 , 673 , 680 , 681 , 682 ) , HeLa (cervical) ( 5 , 342 , 343 , 579 , 580 , 636 , 642 , 643 , 644 , 645 ) , HeLa S3 (cervical) ( 356 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 440 , 441 , 442 , 443 , 444 , 445 , 446 , 540 , 542 , 554 , 650 , 652 , 653 ) , hepatocyte-liver ( 439 , 448 , 539 , 541 , 649 ) , HepG2 (hepatic) ( 450 ) , HES-3 ('stem, embryonic') ( 202 ) , HLE (hepatic) ( 544 ) , HLF (hepatic) ( 449 ) , HOP62 (pulmonary) ( 19 ) , HOS (bone cell) ( 713 ) , HT-29 (intestinal) ( 894 , 895 , 1043 , 1069 , 1070 , 1077 ) , Huh1 (hepatic) ( 545 ) , Huh6 (hepatic) ( 634 ) , Huh7 (hepatic) ( 635 ) , HUVEC (endothelial) ( 603 , 604 , 605 , 606 , 607 , 608 ) , IM95 (gastric) ( 688 ) , J82 (bladder cell) ( 850 ) , JHH-1 (hepatic) ( 633 ) , JHH-2 (hepatic) ( 587 ) , JHH-4 (hepatic) ( 573 ) , JHH-7 (hepatic) ( 584 ) , JIMT-1 (breast cell) ( 165 , 837 , 878 ) , Jurkat (T lymphocyte) ( 21 , 26 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 74 , 75 , 76 , 77 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 102 , 123 , 124 , 125 , 140 , 154 , 155 , 163 , 217 , 218 , 219 , 220 , 237 , 239 , 243 , 244 , 245 , 246 , 256 , 257 , 258 , 259 , 264 , 265 , 266 , 267 , 268 , 269 , 278 , 279 , 280 , 281 , 282 , 289 , 301 , 303 , 324 , 345 , 358 , 361 , 362 , 364 , 396 , 397 , 398 , 418 , 419 , 425 , 426 , 427 , 428 , 436 , 437 , 553 , 583 , 640 , 641 , 651 , 745 , 1086 , 1099 ) , K562 (erythroid) ( 71 , 72 , 73 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 247 , 248 , 249 , 250 , 252 , 253 , 254 , 255 , 317 , 320 , 322 , 323 , 340 , 344 , 359 , 360 , 363 , 365 , 660 , 666 , 667 , 694 , 699 , 725 , 726 , 740 , 741 , 742 , 743 , 744 , 746 , 747 , 748 , 751 , 752 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 823 , 914 , 915 , 916 , 921 , 926 , 932 , 933 , 935 , 936 , 937 , 961 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 1025 , 1107 , 1108 , 1109 ) , KATO III (gastric) ( 527 , 528 , 893 ) , KELLY (neural crest) ( 4 ) , kidney ( 421 , 422 , 423 , 424 , 429 ) , KPL-4 (breast cell) ( 11 ) , Kyse140 (esophageal) ( 296 , 834 , 835 , 944 , 945 , 954 ) , Kyse150 (esophageal) ( 291 ) , Kyse180 (esophageal) ( 299 , 946 ) , Kyse270 (esophageal) ( 294 , 854 , 855 , 856 , 857 , 938 ) , Kyse30 (esophageal) ( 290 , 942 ) , Kyse410 (esophageal) ( 295 , 947 ) , Kyse450 (squamous) ( 297 , 940 ) , Kyse510 (esophageal) ( 293 , 939 ) , Kyse520 (esophageal) ( 292 , 870 ) , Kyse70 (esophageal) ( 298 , 868 , 869 , 871 , 943 ) , L540 (lymphoid) ( 288 , 897 ) , LAN-6 (neural crest) ( 4 , 216 ) , LCLC-103H (pulmonary) ( 879 ) , liver ( 201 , 283 , 284 , 285 , 537 ) , LN18 (glial) ( 691 , 701 , 983 ) , LN229 (glial) ( 984 ) , LN405 (glial) ( 864 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFR (wildtype)] ( 164 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII mutant (aka Delta EGFR, d2-7 EGFR; del. exon 2-7; in-frame loss 801 bp/267 aa in EC domain)] ( 164 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII-ki mutant (deletion of exons 2-7 plus kinase inactive mutation)] ( 164 ) , LN444 (glial) ( 390 , 391 , 392 , 393 , 394 , 395 ) , LOU-NH91 (squamous) ( 9 , 19 , 976 , 1018 ) , lung ( 6 , 8 , 9 , 10 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 223 , 225 , 227 , 228 , 274 , 275 , 276 , 277 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 318 , 319 , 321 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 430 , 431 , 432 , 433 , 434 , 435 , 452 , 453 , 454 , 455 , 456 , 459 , 460 , 461 , 462 , 523 , 529 , 530 , 533 , 534 , 535 , 536 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 588 , 589 , 590 , 591 , 592 , 593 , 597 , 598 , 617 , 620 , 624 , 625 , 626 , 627 , 628 , 629 , 637 , 638 , 675 , 676 , 677 , 683 , 684 , 703 , 704 , 705 , 727 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 803 , 804 , 805 , 843 , 845 , 847 , 858 , 859 , 860 , 861 , 862 , 863 , 887 , 903 , 904 , 917 , 918 , 919 , 920 , 934 , 948 , 949 , 950 , 955 , 956 , 957 , 958 , 959 , 963 , 964 , 966 , 967 , 968 , 970 , 971 , 972 , 973 , 974 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1004 , 1005 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1038 , 1039 , 1040 , 1044 , 1050 , 1051 , 1052 , 1053 , 1054 , 1061 , 1062 , 1065 , 1066 , 1067 , 1068 , 1076 ) , LXF-289 (pulmonary) ( 880 ) , M059J (glial) ( 982 ) , M059K (glial) ( 1021 ) , MCAS (ovarian) ( 213 ) , MCF-10A (breast cell) [CSFR (human), transfection] ( 214 ) , MCF-10A (breast cell) ( 14 , 214 , 1055 , 1056 , 1080 , 1088 , 1089 ) , MDA-MB-157 (breast cell) ( 165 ) , MDA-MB-175vii (breast cell) ( 165 ) , MDA-MB-231 (breast cell) ( 14 , 19 ) , MDA-MB-415 (breast cell) ( 730 ) , MDA-MB-435S (breast cell) ( 165 , 1057 ) , MDA-MB-468 (breast cell) ( 14 , 19 , 165 ) , MDAH2774 (ovarian) ( 910 ) , MG63 (bone cell) ( 20 , 712 ) , MKN-1 (gastric) ( 689 ) , MKN-45 (gastric) ( 16 , 25 , 33 , 34 , 35 , 36 , 37 , 43 , 66 , 78 , 79 , 99 , 100 , 101 , 120 , 121 , 238 , 260 , 261 , 262 , 263 , 270 , 271 , 272 , 339 , 341 , 357 , 595 , 596 , 702 , 753 , 900 ) , MKN-74 (gastric) ( 697 ) , MNNG-HOS (bone cell) ( 20 , 1082 ) , muscle ( 20 ) , NCCIT (epithelial) ( 326 ) , NCI-H1299 (pulmonary) ( 1019 ) , NCI-H1355 (pulmonary) ( 8 , 874 ) , NCI-H1435 (pulmonary) ( 1002 ) , NCI-H1437 (pulmonary) ( 1045 ) , NCI-H1648 (pulmonary) ( 19 , 1020 ) , NCI-H1650 (pulmonary) ( 27 , 28 , 29 , 30 , 31 , 32 , 45 , 104 , 105 , 112 , 113 , 702 , 1017 , 1027 , 1085 , 1104 ) , NCI-H1651 (pulmonary) ( 901 ) , NCI-H1666 (pulmonary) ( 702 , 1029 ) , NCI-H1693 (pulmonary) ( 1023 ) , NCI-H1703 (squamous) ( 9 , 18 , 357 , 464 , 465 , 585 , 733 , 1064 , 1083 ) , NCI-H1734 (pulmonary) ( 702 , 1016 , 1084 , 1091 ) , NCI-H1781 (pulmonary) ( 10 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 546 , 547 ) , NCI-H1792 (pulmonary) ( 8 , 552 ) , NCI-H1793 (pulmonary) ( 1024 ) , NCI-H1838 (pulmonary) ( 885 ) , NCI-H1869 (squamous) ( 1009 ) , NCI-H1944 (pulmonary) ( 1041 , 1047 ) , NCI-H1975 (pulmonary) ( 702 , 1028 , 1087 ) , NCI-H2023 (pulmonary) ( 1022 ) , NCI-H2030 (pulmonary) ( 980 ) , NCI-H2052 (pulmonary) ( 882 ) , NCI-H2073 (pulmonary) ( 9 , 886 ) , NCI-H2126 (pulmonary) [LKB1 (human), no information] ( 657 ) , NCI-H2170 (squamous) ( 1079 ) , NCI-H2172 (pulmonary) ( 899 , 1033 ) , NCI-H2228 (pulmonary) ( 10 , 12 , 639 , 975 , 1059 ) , NCI-H226 (pulmonary) ( 1101 ) , NCI-H2286 (pulmonary) ( 979 ) , NCI-H23 (pulmonary) ( 8 ) , NCI-H2342 (pulmonary) ( 9 , 884 ) , NCI-H2452 (pulmonary) ( 877 ) , NCI-H28 (pulmonary) ( 873 ) , NCI-H292 (pulmonary) ( 287 ) , NCI-H3122 (pulmonary) ( 10 , 106 , 107 , 114 , 115 ) , NCI-H322 (pulmonary) ( 19 ) , NCI-H3255 (pulmonary) ( 17 , 46 , 357 , 594 , 702 , 749 , 750 , 844 , 1032 , 1072 ) , NCI-H358 (pulmonary) ( 702 , 1026 ) , NCI-H441 (pulmonary) ( 8 ) , NCI-H460 (pulmonary) ( 19 , 1096 , 1097 , 1098 , 1100 ) , NCI-H520 (squamous) ( 1034 , 1035 ) , NCI-H596 (pulmonary) ( 902 , 922 , 977 ) , NCI-H661 (pulmonary) ( 10 , 1042 ) , NCI-H838 (pulmonary) ( 1046 ) , nerve ( 20 ) , NT2 (testicular) ( 325 ) , NUGC-2 (gastric) ( 695 ) , NUGC-3 (gastric) ( 690 ) , NUGC-4 (gastric) ( 696 ) , OCI-ly18 (B lymphocyte) ( 1090 ) , OCUG-1 ( 632 ) , OV90 (ovarian) ( 906 , 924 ) , ovary ( 7 , 230 , 231 , 232 , 233 , 240 , 241 , 302 , 304 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 715 , 717 , 718 , 719 ) , OVCAR8 (ovarian) ( 236 ) , OVKATE (ovarian) ( 205 , 207 , 212 ) , OVMANA (ovarian) [RAIG1 (human), knockdown] ( 53 , 54 ) , OVMANA (ovarian) ( 55 , 166 , 206 , 210 ) , OVSAHO (ovarian) ( 208 , 235 ) , OZ (bile-duct cell) [RAIG1 (human), knockdown] ( 56 ) , OZ (bile-duct cell) ( 586 ) , PA-1 (ovarian) ( 907 , 911 ) , PC3 (prostate cell) ( 1092 ) , PC9 (pulmonary) ( 6 ) , PC9-IR (pulmonary) ( 6 , 815 , 875 ) , PC9-TAR (pulmonary) ( 818 , 876 ) , PLC/PRF/5 (hepatic) ( 543 ) , RC-K8 (B lymphocyte) ( 960 ) , RD18 (muscle cell) ( 20 ) , RERF-GC-1B (gastric) ( 686 ) , RMUG-S (ovarian) ( 211 ) , SACC-83 (salivary gland) ( 600 , 602 ) , salivary gland ( 581 , 582 ) , Saos-2 (bone cell) ( 20 ) , Scaber (squamous) ( 838 ) , SCH (gastric) ( 698 ) , SH-SY5Y (neural crest) ( 4 ) , SJSA-1 (bone cell) ( 722 ) , SK-HEP-1 (endothelial) ( 525 ) , SK-LMS-1 (muscle cell) ( 20 ) , skin ( 366 , 367 , 368 , 369 , 370 , 371 , 372 , 556 , 567 , 568 , 569 , 570 , 571 , 572 , 575 , 630 , 646 , 647 ) , SKNFI (neural crest) ( 4 , 865 ) , SKNSH (neural crest) ( 969 ) , SMS-KCN-A (neural crest) ( 4 , 215 ) , SNU-1079 (hepatic) ( 577 ) , SNU-1196 (hepatic) ( 574 ) , SNU-16 (gastric) ( 891 ) , SNU-398 (hepatic) ( 576 ) , SNU-449 (hepatic) ( 524 ) , SNU-478 (bile-duct cell) ( 578 ) , SNU-C2B (intestinal) ( 888 , 889 ) , stomach ( 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 618 , 619 , 621 , 622 , 623 , 664 , 665 , 678 , 679 , 685 ) , SW1710 (bladder cell) ( 813 ) , SW1783 (glial) ( 978 ) , SW480 (intestinal) ( 1 , 706 , 707 , 708 , 709 , 710 , 1036 ) , SW620 (intestinal) ( 853 , 951 , 952 , 1037 , 1093 ) , T1-73 (bone cell) ( 723 ) , T98G (glial) ( 1007 ) , thymus ( 141 , 142 , 143 , 144 ) , thyroid ( 692 , 693 ) , TOV21G (ovarian) ( 923 ) , TYK-nu (ovarian) ( 209 , 234 ) , U-118MG (glial) ( 110 , 111 , 122 , 631 , 1071 ) , U-138 MG (glial) ( 866 ) , U2OS (bone cell) ( 20 ) , UM-UC-1 (bladder cell) ( 867 ) , VACO432 (ovarian) ( 1003 ) , WM239A (melanocyte) ( 3 ) , ZR-75-1 (breast cell) ( 165 ) , ZR-75-30 (breast cell) ( 165 , 830 )

Upstream Regulation
Regulatory protein:
CSFR (human) ( 214 ) , EGFR (human) ( 164 )
Putative in vivo kinases:
LYN (human) ( 14 ) , Src (human) ( 1 )
Treatments:
ischemia ( 7 ) , saracatinib ( 1 ) , selumetinib ( 3 ) , Su11274 ( 357 ) , vemurafenib ( 3 )

Downstream Regulation
Effects of modification on PEAK1:
molecular association, regulation ( 1 )
Effects of modification on biological processes:
cell growth, induced ( 14 ) , cell motility, induced ( 1 , 14 ) , cytoskeletal reorganization ( 14 )
Induce interaction with:
GRB2 (human) ( 14 ) , SHC1 (human) ( 1 ) , tensin 3 (rat) ( 1 )

Disease / Diagnostics Relevance
Relevant diseases:
cholangiocellular carcinoma ( 201 )

References 

1

Zuidema A, et al. (2022) PEAK1 Y635 phosphorylation regulates cell migration through association with Tensin3 and integrins. J Cell Biol 221
35687021   Curated Info

2

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

3

Stuart SA, et al. (2015) A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics 14, 1599-615
25850435   Curated Info

4

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

5

Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info

6

Yoshida T, et al. (2014) Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20, 4059-74
24919575   Curated Info

7

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

8

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Tzouros M, et al. (2013) Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics. Mol Cell Proteomics 12, 3339-49
23882028   Curated Info

12

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

13

Johnson H, Lescarbeau RS, Gutierrez JA, White FM (2013) Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion. J Proteome Res 12, 1856-67
23438512   Curated Info

14

Croucher DR, et al. (2013) Involvement of Lyn and the Atypical Kinase SgK269/PEAK1 in a Basal Breast Cancer Signaling Pathway. Cancer Res 73, 1969-80
23378338   Curated Info

15

Rikova K (2012) CST Curation Set: 16140; Year: 2012; Biosample/Treatment: cell line, A549/iressa, gleevec, crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

16

Rikova K (2012) CST Curation Set: 16137; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

17

Rikova K (2012) CST Curation Set: 16138; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

18

Rikova K (2012) CST Curation Set: 16139; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

19

Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68
22617229   Curated Info

20

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

21

Zhou J (2012) CST Curation Set: 14432; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

22

Beli P, et al. (2012) Proteomic Investigations Reveal a Role for RNA Processing Factor THRAP3 in the DNA Damage Response. Mol Cell 46, 212-25
22424773   Curated Info

23

Rikova K (2012) CST Curation Set: 14270; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 1mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

24

Rikova K (2012) CST Curation Set: 14271; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 2mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

25

Mulhern D (2012) CST Curation Set: 14193; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

26

Zhou J (2012) CST Curation Set: 14185; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

27

Possemato A (2012) CST Curation Set: 14060; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

28

Possemato A (2012) CST Curation Set: 14061; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

29

Possemato A (2012) CST Curation Set: 14062; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

30

Possemato A (2012) CST Curation Set: 14063; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

31

Possemato A (2012) CST Curation Set: 14058; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

32

Possemato A (2012) CST Curation Set: 14059; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

33

Zhou J (2012) CST Curation Set: 14008; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

34

Zhou J (2012) CST Curation Set: 14009; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

35

Zhou J (2012) CST Curation Set: 14010; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

36

Zhou J (2012) CST Curation Set: 13885; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

37

Mulhern D (2012) CST Curation Set: 13932; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

38

Tucker M (2012) CST Curation Set: 13493; Year: 2012; Biosample/Treatment: cell line, 23132/87[RAIG1(knockdown)]/GPRC5A knockdown; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

39

Tucker M (2012) CST Curation Set: 13494; Year: 2012; Biosample/Treatment: cell line, 23132/87/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

40

Rikova K (2012) CST Curation Set: 13730; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 2/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

41

Rikova K (2012) CST Curation Set: 13731; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 3/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

42

Rikova K (2012) CST Curation Set: 13729; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 1/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

43

Zhou J (2012) CST Curation Set: 13688; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

44

Possemato A (2012) CST Curation Set: 13551; Year: 2012; Biosample/Treatment: cell line, A549/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

45

Possemato A (2012) CST Curation Set: 13552; Year: 2012; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

46

Possemato A (2012) CST Curation Set: 13555; Year: 2012; Biosample/Treatment: cell line, NCI-H3255/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

Possemato A (2012) CST Curation Set: 13558; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

48

Possemato A (2012) CST Curation Set: 13559; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

Possemato A (2012) CST Curation Set: 13560; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

Tucker M (2012) CST Curation Set: 13495; Year: 2012; Biosample/Treatment: cell line, Colo-680N[RAIG1(knockdown)]/GPRC5A knockdown; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

51

Tucker M (2012) CST Curation Set: 13496; Year: 2012; Biosample/Treatment: cell line, Colo-680N[RAIG1(knockdown)]/GPRC5A knockdown; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Tucker M (2012) CST Curation Set: 13497; Year: 2012; Biosample/Treatment: cell line, Colo-680N/untreated; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Tucker M (2012) CST Curation Set: 13498; Year: 2012; Biosample/Treatment: cell line, OVMANA[RAIG1(knockdown)]/GPRC5A knockdown; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

54

Tucker M (2012) CST Curation Set: 13499; Year: 2012; Biosample/Treatment: cell line, OVMANA[RAIG1(knockdown)]/GPRC5A knockdown; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

Tucker M (2012) CST Curation Set: 13500; Year: 2012; Biosample/Treatment: cell line, OVMANA/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

Tucker M (2012) CST Curation Set: 13501; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

57

Zhou J (2012) CST Curation Set: 12609; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

58

Zhou J (2012) CST Curation Set: 12610; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

59

Zhou J (2012) CST Curation Set: 12611; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Zhou J (2012) CST Curation Set: 12612; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

61

Mulhern D (2012) CST Curation Set: 13337; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

62

Mulhern D (2012) CST Curation Set: 13338; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

Mulhern D (2012) CST Curation Set: 13335; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

64

Mulhern D (2012) CST Curation Set: 13336; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

65

Rikova K (2012) CST Curation Set: 13324; Year: 2012; Biosample/Treatment: cell line, A549/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

Rikova K (2012) CST Curation Set: 13326; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

68

Mulhern D (2012) CST Curation Set: 13332; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

69

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

70

Rikova K (2012) CST Curation Set: 13330; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

Mulhern D (2011) CST Curation Set: 13266; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

72

Mulhern D (2011) CST Curation Set: 13267; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

73

Mulhern D (2011) CST Curation Set: 13268; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

74

Mulhern D (2011) CST Curation Set: 12689; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Mulhern D (2011) CST Curation Set: 12691; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Mulhern D (2011) CST Curation Set: 13031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

77

Mulhern D (2011) CST Curation Set: 13033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

78

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

79

Mulhern D (2011) CST Curation Set: 12853; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Mulhern D (2011) CST Curation Set: 12643; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Mulhern D (2011) CST Curation Set: 12644; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Mulhern D (2011) CST Curation Set: 12579; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Mulhern D (2011) CST Curation Set: 12475; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Zhou J (2011) CST Curation Set: 12495; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Zhou J (2011) CST Curation Set: 12496; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Zhou J (2011) CST Curation Set: 12497; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

Zhou J (2011) CST Curation Set: 12344; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

88

Zhou J (2011) CST Curation Set: 12345; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Zhou J (2011) CST Curation Set: 12346; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

90

Zhou J (2011) CST Curation Set: 12347; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

91

Zhou J (2011) CST Curation Set: 12348; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

92

Zhou J (2011) CST Curation Set: 12317; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

93

Zhou J (2011) CST Curation Set: 12318; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

94

Zhou J (2011) CST Curation Set: 12319; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

95

Zhou J (2011) CST Curation Set: 12320; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Zhou J (2011) CST Curation Set: 12030; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

97

Zhou J (2011) CST Curation Set: 12031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

98

Zhou J (2011) CST Curation Set: 12033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

99

Moritz A (2011) CST Curation Set: 12371; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

100

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Moritz A (2011) CST Curation Set: 12258; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Organ SL, et al. (2011) Quantitative Phospho-Proteomic Profiling of Hepatocyte Growth Factor (HGF)-MET Signaling in Colorectal Cancer. J Proteome Res 10, 3200-11
21609022   Curated Info

104

Possemato A (2011) CST Curation Set: 11905; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Possemato A (2011) CST Curation Set: 11906; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Possemato A (2011) CST Curation Set: 11907; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Possemato A (2011) CST Curation Set: 11912; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Possemato A (2011) CST Curation Set: 11924; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Possemato A (2011) CST Curation Set: 11925; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Guo A (2011) CST Curation Set: 11646; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

Guo A (2011) CST Curation Set: 11647; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Guo A (2011) CST Curation Set: 11648; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

Ren H (2011) CST Curation Set: 11772; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

Ren H (2011) CST Curation Set: 11775; Year: 2011; Biosample/Treatment: cell line, RP92/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

Ren H (2011) CST Curation Set: 11776; Year: 2011; Biosample/Treatment: cell line, RP93/untreated; Disease: non-small cell squamous cell lung carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

Ren H (2011) CST Curation Set: 11777; Year: 2011; Biosample/Treatment: cell line, RP94/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

130

Ren H (2011) CST Curation Set: 11778; Year: 2011; Biosample/Treatment: cell line, RP95/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

Ren H (2011) CST Curation Set: 11781; Year: 2011; Biosample/Treatment: cell line, RP98/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

132

Ren H (2011) CST Curation Set: 11783; Year: 2011; Biosample/Treatment: cell line, RP100/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

Ren H (2011) CST Curation Set: 11784; Year: 2011; Biosample/Treatment: cell line, RP101/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

134

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

135

Ren H (2011) CST Curation Set: 11786; Year: 2011; Biosample/Treatment: cell line, RP103/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

136

Ren H (2011) CST Curation Set: 11787; Year: 2011; Biosample/Treatment: cell line, RP104/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

137

Ren H (2011) CST Curation Set: 11788; Year: 2011; Biosample/Treatment: cell line, RP105/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

138

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

139

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

140

Possemato A (2011) CST Curation Set: 11713; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

141

Li Y (2011) CST Curation Set: 10458; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

142

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

143

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

144

Li Y (2011) CST Curation Set: 10461; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

Li Y (2011) CST Curation Set: 10515; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

Li Y (2011) CST Curation Set: 10516; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

Li Y (2011) CST Curation Set: 10517; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

148

Li Y (2011) CST Curation Set: 10518; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

149

Li Y (2011) CST Curation Set: 10519; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

150

Li Y (2011) CST Curation Set: 10522; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

151

Li Y (2011) CST Curation Set: 10523; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

152

Li Y (2011) CST Curation Set: 10525; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

153

Li Y (2011) CST Curation Set: 10527; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

154

Possemato A (2011) CST Curation Set: 11632; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

155

Possemato A (2011) CST Curation Set: 11633; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

Tucker M (2011) CST Curation Set: 10943; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

Tucker M (2011) CST Curation Set: 10945; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

Tucker M (2011) CST Curation Set: 10947; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

Tucker M (2011) CST Curation Set: 10949; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

160

Tucker M (2011) CST Curation Set: 10951; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

161